The Clinical and Molecular Spectrum of GM1 Gangliosidosis

This publication has 26 references indexed in Scilit:

• Oligosaccharide Analysis in Urine by MALDI-TOF Mass Spectrometry for the Diagnosis of Lysosomal Storage Diseases
  Clinical Chemistry, 2013
• GM1 gangliosidosis and Morquio B disease: An update on genetic alterations and clinical findings
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
• Phenotype determining alleles in GM1 gangliosidosis patients bearing novel GLB1 mutations
  Clinical Genetics, 2010
• GM1 gangliosidosis: Review of clinical, molecular, and therapeutic aspects
  Molecular Genetics and Metabolism, 2008
• Identification of 14 novel GLB1 mutations, including five deletions, in 19 patients with GM1 gangliosidosis from South America
  Clinical Genetics, 2007
• Twenty-one novel mutations in the GLB1 gene identified in a large group of GM1-gangliosidosis and Morquio B patients: possible common origin for the prevalent p.R59H mutation among gypsies
  Human Mutation, 2006
• Mutation analyses in 17 patients with deficiency in acid β-galactosidase: three novel point mutations and high correlation of mutation W273L with Morquio disease type B
  Human Genetics, 2001
• Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure–function studies of lysosomal β-galactosidase and the non-lysosomal β-galactosidase-like protein
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1999
• Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.
  Journal of Clinical Investigation, 1994
• Clinical and Molecular Heterogeneity in Hereditary β-Galactosidase Deficiency
  Developmental Neuroscience, 1991